Neurology

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCETEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TORONTO, July 27, 2025 /PRNewswire/ -- The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025…

2 weeks ago
Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History StudyAlterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to…

3 weeks ago
AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALSAB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB…

3 weeks ago
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive OfficerTenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

Proven drug development leader to drive company’s pipeline of highly CNS-penetrant and precision-designed peripherally restricted small molecules toward clinical milestonesSOUTH SAN…

3 weeks ago
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive OfficerTenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

Proven drug development leader to drive company’s pipeline of highly CNS-penetrant and precision-designed peripherally restricted small molecules toward clinical milestonesSOUTH SAN…

3 weeks ago
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)

ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the aflibercept arm…

3 weeks ago
Natus announces Moberg CNS integration with NeuroWorks for advanced EEGNatus announces Moberg CNS integration with NeuroWorks for advanced EEG

Natus announces Moberg CNS integration with NeuroWorks for advanced EEG

MIDDLETON, Wis., July 22, 2025 /PRNewswire/ -- Natus Medical Incorporated is continuing its commitment to innovation and expanding the functionality of…

3 weeks ago
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of DirectorsBioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors

Seasoned leaders bring deep expertise in neuroscience drug development, strategic growth, and corporate finance to support BioVie’s missionCARSON CITY, Nev.,…

3 weeks ago
NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025

NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025

– NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th –NAARDEN, the Netherlands and MIAMI, July…

3 weeks ago